Suchergebnisse - "Kale, Ajinath"

PubPharm (18)

1

Voclosporin : Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis

enthalten in: Cells | 2023

von Kale, A. | Shelke, V. | Lei, Y. | +2

2

Epigenetic regulation of mitochondrial-endoplasmic reticulum dynamics in kidney diseases

enthalten in: Journal of cellular physiology | 2023

von Shelke, V. | Yelgonde, V. | Kale, A. | +2

3

Hippo signaling in acute kidney injury to chronic kidney disease transition : Current understandings and future targets

enthalten in: Drug discovery today | 2023

von Habshi, T. | Shelke, V. | Kale, A. | +2

4

Lupus Nephritis : New and Emerging Biologic and Targeted Therapies

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2023

von Kale, A. | Lech, M. | Anders, H. | +1

5

Nutraceuticals and network pharmacology approach for acute kidney injury : A review from the drug discovery aspect

enthalten in: Fitoterapia | 2023

von Dagar, N. | Kale, A. | Jadhav, H. | +1

6

Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury

enthalten in: Food & function | 2023

von Shelke, V. | Kale, A. | Dagar, N. | +2

7

Lupus Nephritis: New and Emerging Biologic and Targeted Therapies

enthalten in: BioDrugs | 2023

von Kale, A. | Lech, M. | Anders, H. | +1

8

Lupus Nephritis: New and Emerging Biologic and Targeted Therapies

enthalten in: BioDrugs | 2023

von Kale, A. | Lech, M. | Anders, H. | +1

9

Lupus Nephritis: New and Emerging Biologic and Targeted Therapies

enthalten in: BioDrugs | 2023

von Kale, A. | Lech, M. | Anders, H. | +1

10

Klotho in kidney diseases : a crosstalk between the renin-angiotensin system and endoplasmic reticulum stress

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Kale, A. | Sankrityayan, H. | Anders, H. | +1